Episode Details
Back to Episodes
MDxHealth Shuts Down UTI Test, Focuses on Prostate Diagnostics
Published 2 days, 13 hours ago
Description
MDxHealths Q1 2026 earnings reveal a strategic shift: shutting down Resolve UTI test and Plano lab, focusing on core prostate cancer ops. Revenue hits $27.4M, up 11% YoY, despite $10.4M Medicare recoupment demand. Gross margins remain strong at 62.9%, cash at $43.2M. New guidance for core cancer revenue is $110-115M, with AI integration and partnerships driving growth.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/7af15943a90fc5e7